HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guideline removal of atropine and survival after adult in-hospital cardiac arrest with a non-shockable rhythm.

AbstractAIM:
To determine whether the removal of atropine from the 2010 ACLS guidelines for non-shockable cardiac arrests was associated with a change in survival.
METHODS:
Using the Get With The Guidelines®-Resuscitation registry, we included adults with an index in-hospital cardiac arrest between 2006 and 2015. The primary outcome was survival to hospital discharge. Secondary outcomes included return of spontaneous circulation and favorable functional outcome. An interrupted time-series analysis was used to compare survival before (pre-guidelines) and after (post-guidelines) introduction of the 2010 guidelines. A difference-in-difference approach was used to compare the interrupted time-series results between the non-shockable and shockable cohorts to account for guideline changes unrelated to atropine.
RESULTS:
We included 20,499 non-shockable and 3968 shockable cardiac arrests. Patient characteristics were similar between the pre-guidelines and post-guidelines period. Atropine was used for 8653 (87%) non-shockable and 680 (35%) shockable cardiac arrests in the pre-guidelines period and 3643 (35%) non-shockable and 320 (16%) shockable cardiac arrests in the post-guidelines period. The change over time in survival from the pre-guidelines to the post-guidelines period was not significantly different for the non-shockable compared to the shockable cohort (risk difference: 2.0% [95%CI: -0.8, 4.8] per year, p = 0.17). The immediate change in survival after introducing the guidelines was also not different between the cohorts (risk difference: 3.5% [95%CI: -2.6, 9.7], p = 0.26). Results were similar for the secondary outcomes and in multiple sensitivity analyses.
CONCLUSIONS:
The removal of atropine from the 2010 guidelines was not associated with a significant change in survival.
AuthorsMathias J Holmberg, Ari Moskowitz, Sebastian Wiberg, Anne V Grossestreuer, Tuyen Yankama, Lise Witten, Sarah M Perman, Michael W Donnino, Lars W Andersen, American Heart Association’s Get With The Guidelines®-Resuscitation Investigators
JournalResuscitation (Resuscitation) Vol. 137 Pg. 69-77 (04 2019) ISSN: 1873-1570 [Electronic] Ireland
PMID30771452 (Publication Type: Journal Article, Observational Study, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2019 Elsevier B.V. All rights reserved.
Chemical References
  • Anti-Arrhythmia Agents
  • Atropine
Topics
  • Aged
  • Anti-Arrhythmia Agents (administration & dosage)
  • Atropine (administration & dosage)
  • Electric Countershock
  • Female
  • Heart Arrest (drug therapy, mortality)
  • Humans
  • Interrupted Time Series Analysis
  • Male
  • Middle Aged
  • Practice Guidelines as Topic
  • Propensity Score
  • Prospective Studies
  • Registries
  • Survival Rate
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: